Advertisement

Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)?

  • Jacopo Francesco Imberti
    Affiliations
    Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

    Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
    Search for articles by this author
  • Giuseppe Boriani
    Affiliations
    Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
    Search for articles by this author
  • Gregory Y.H. Lip
    Correspondence
    Corresponding author.
    Affiliations
    Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

    Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
    Search for articles by this author
      Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide but the actual incidence and prevalence of AF may be underestimated because approximately 40% of patients are asymptomatic and often undiagnosed until complications occur [
      • Boriani G.
      • Laroche C.
      • Diemberger I.
      • Fantecchi E.
      • Popescu M.I.
      • Rasmussen L.H.
      • et al.
      Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry.
      ]. AF confers a significant healthcare burden [
      • Burdett P.
      • Lip G.Y.H.
      Atrial fibrillation in the United Kingdom: predicting costs of an emerging epidemic recognising and forecasting the cost drivers of atrial fibrillation-related costs.
      ], necessitating a much more holistic or integrated approach to AF care, given the proven beneficial impacts on clinical outcomes [
      • Yoon M.
      • Yang P.S.
      • Jang E.
      • Yu H.T.
      • Kim T.H.
      • Uhm J.S.
      • et al.
      Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated care management: a nationwide cohort study.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Boriani G.
        • Laroche C.
        • Diemberger I.
        • Fantecchi E.
        • Popescu M.I.
        • Rasmussen L.H.
        • et al.
        Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry.
        Am J Med. 2015; 128 (e2): 509-518
        • Burdett P.
        • Lip G.Y.H.
        Atrial fibrillation in the United Kingdom: predicting costs of an emerging epidemic recognising and forecasting the cost drivers of atrial fibrillation-related costs.
        Eur Heart J Qual Care Clin Outcomes. 2020;
        • Yoon M.
        • Yang P.S.
        • Jang E.
        • Yu H.T.
        • Kim T.H.
        • Uhm J.S.
        • et al.
        Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated care management: a nationwide cohort study.
        Thromb Haemost. 2019; 119: 1695-1703
        • Potpara T.S.
        • Lip G.Y.H.
        • Blomstrom-Lundqvist C.
        • Boriani G.
        • Van Gelder I.C.
        • Heidbuchel H.
        • et al.
        The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): a novel approach to in-depth characterization (Rather than Classification) of atrial fibrillation.
        Thromb Haemost. 2021; 121: 270-278
        • Hindricks G.
        • Potpara T.
        • Dagres N.
        • Arbelo E.
        • Bax J.J.
        • Blomström-Lundqvist C.
        • et al.
        2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
        Eur Heart J. 2020;
        • Lowres N.
        • Olivier J.
        • Chao T.F.
        • Chen S.A.
        • Chen Y.
        • Diederichsen A.
        • et al.
        Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals.
        PLoS Med. 2019; 16e1002903
        • Li Y.G.
        • Pastori D.
        • Farcomeni A.
        • Yang P.S.
        • Jang E.
        • Joung B.
        • et al.
        A simple clinical risk score (C2HEST) for predicting incident atrial fibrillation in asian subjects: derivation in 471,446 chinese subjects, with internal validation and external application in 451,199 korean subjects.
        Chest. 2019; 155: 510-518
        • Li Y.G.
        • Pastori D.
        • Miyazawa K.
        • Shahid F.
        • Lip G.Y.H.
        Identifying at-risk patients for sustained atrial high-rate episodes using the C.
        J Am Heart Assoc. 2021; 10e017519
        • Boriani G.
        • Vitolo M.
        • Imberti J.F.
        • Potpara T.S.
        • Lip G.Y.H.
        What do we do about atrial high rate episodes?.
        Eur Heart J Suppl. 2020; 22: O42-O52
        • Guo Y.
        • Wang H.
        • Zhang H.
        • Chen Y.
        • Lip G.Y.H.
        Population-based screening or targeted screening based on initial clinical risk assessment for atrial fibrillation: a report from the huawei heart study.
        J Clin Med. 2020; 9
        • Li Y.-G.
        • Bai J.
        • Zhou G.
        • Li J.
        • Wei Y.
        • Sun L.
        • et al.
        Refining age stratum of the C2HEST score for predicting incident atrial fibrillation in a hospital-based Chinese population.
        Eur J Intern Med. 2021; (DOI:https://doi.org/10.1016/j.ejim.2021.04.014)
        • Li Y.G.
        • Bisson A.
        • Bodin A.
        • Herbert J.
        • Grammatico-Guillon L.
        • Joung B.
        • et al.
        C2HEST score and prediction of incident atrial fibrillation in poststroke patients: a french nationwide study.
        J Am Heart Assoc. 2019; 8e012546
        • Himmelreich J.C.L.
        • Veelers L.
        • Lucassen W.A.M.
        • Schnabel R.B.
        • Rienstra M.
        • van Weert H.C.P.M.
        • et al.
        Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis.
        Europace. 2020; 22: 684-694
        • Schnabel R.B.
        • Larson M.G.
        • Yamamoto J.F.
        • Sullivan L.M.
        • Pencina M.J.
        • Meigs J.B.
        • et al.
        Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.
        Circulation. 2010; 121: 200-207
        • Börschel C.S.
        • Ohlrogge A.H.
        • Geelhoed B.
        • Niiranen T.
        • Havulinna A.S.
        • Palosaari T.
        • et al.
        Risk prediction of atrial fibrillation in the community combining biomarkers and genetics.
        Europace. 2021;
        • Lim D.J.
        • Ambale-Ventakesh B.
        • Ostovaneh M.R.
        • Zghaib T.
        • Ashikaga H.
        • Wu C.
        • et al.
        Change in left atrial function predicts incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.
        Eur Heart J Cardiovasc Imaging. 2019; 20: 979-987
        • Camelo-Castillo A.
        • Rivera-Caravaca J.M.
        • Marín F.
        • Vicente V.
        • Lip G.Y.H.
        • Roldán V.
        Predicting adverse events beyond stroke and bleeding with the ABC-stroke and ABC-bleeding scores in patients with atrial fibrillation: the murcia AF project.
        Thromb Haemost. 2020; 120: 1200-1207
        • Esteve-Pastor M.A.
        • Roldán V.
        • Rivera-Caravaca J.M.
        • Ramírez-Macías I.
        • Lip G.Y.H.
        • Marín F.
        The use of biomarkers in clinical management guidelines: a critical appraisal.
        Thromb Haemost. 2019; 119: 1901-1919